Rohto Pharmaceutical Co.,Ltd.
4527.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥77,161 | ¥89,210 | ¥79,951 | ¥72,791 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥69,880 | ¥69,115 | ¥60,656 | ¥51,682 |
| Inventory | ¥61,580 | ¥46,657 | ¥41,062 | ¥33,527 |
| Other Curr. Assets | ¥9,258 | ¥9,777 | ¥8,577 | ¥6,306 |
| Total Curr. Assets | ¥217,879 | ¥214,759 | ¥190,246 | ¥164,306 |
| Property Plant & Equip (Net) | ¥90,451 | ¥68,607 | ¥66,182 | ¥62,839 |
| Goodwill | ¥47,494 | ¥2,285 | ¥2,564 | ¥2,954 |
| Intangibles | ¥8,575 | ¥6,932 | ¥6,997 | ¥6,338 |
| Long-Term Investments | ¥46,427 | ¥43,731 | ¥32,629 | ¥27,471 |
| Tax Assets | ¥3,975 | ¥3,869 | ¥5,371 | ¥5,297 |
| Other NC Assets | ¥7,074 | ¥5,992 | ¥5,686 | ¥5,419 |
| Total NC Assets | ¥203,996 | ¥131,416 | ¥119,429 | ¥110,318 |
| Other Assets | ¥0 | ¥3 | ¥2 | ¥3 |
| Total Assets | ¥421,875 | ¥346,175 | ¥309,677 | ¥274,627 |
| Liabilities | – | – | – | – |
| Payables | ¥22,056 | ¥21,123 | ¥18,718 | ¥16,269 |
| Short-Term Debt | ¥7,035 | ¥5,304 | ¥4,177 | ¥8,033 |
| Tax Payable | ¥0 | ¥5,071 | ¥6,230 | ¥3,185 |
| Deferred Revenue | ¥0 | ¥5,071 | ¥30,592 | ¥22,539 |
| Other Curr. Liab. | ¥55,316 | ¥24,798 | ¥2,313 | ¥5,293 |
| Total Curr. Liab. | ¥94,608 | ¥87,087 | ¥80,162 | ¥71,488 |
| LT Debt | ¥43,188 | ¥5,190 | ¥7,516 | ¥13,350 |
| Deferred Rev, NC | ¥0 | ¥1,498 | ¥3,146 | ¥3,387 |
| Deferred Tax Liab, NC | ¥2,081 | ¥1,597 | ¥1,173 | ¥1,450 |
| Other NC Liab. | ¥3,370 | ¥2,266 | ¥2,604 | ¥1,037 |
| Total NC Liab. | ¥55,825 | ¥12,055 | ¥14,439 | ¥19,311 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥1,498 | ¥1,184 | ¥1,184 |
| Total Liabilities | ¥150,433 | ¥99,142 | ¥94,601 | ¥90,799 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥6,504 | ¥6,504 | ¥6,504 | ¥6,504 |
| Retained Earnings | ¥228,442 | ¥209,399 | ¥184,005 | ¥162,195 |
| AOCI | ¥35,086 | ¥30,843 | ¥18,705 | ¥8,735 |
| Other Equity | ¥2 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥260,095 | ¥246,323 | ¥209,568 | ¥178,285 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥11,345 | ¥710 | ¥5,508 | ¥5,543 |
| Total Liab. & Tot. Equity | ¥421,875 | ¥346,175 | ¥309,677 | ¥274,627 |
| Net Debt | -¥26,938 | -¥78,716 | -¥68,258 | -¥51,408 |